Cite
HARVARD Citation
Palma, J. et al. (n.d.). 1426PLongitudinal plasma monitoring of subjects treated with EGFR-TKIs allows better understanding of evolution of acquired resistance and can inform optimal treatment strategies. Annals of oncology. p. . [Online].